| Item Type | Name |
|
Academic Article
|
Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis.
|
|
Academic Article
|
Noradrenergic regulation of inflammatory gene expression in brain.
|
|
Academic Article
|
IFN-beta1a (Rebif) modifies the expression of microfilament-associated cell-cell contacts in C6 glioma cells.
|
|
Academic Article
|
Intrinsic regulation of brain inflammatory responses.
|
|
Academic Article
|
Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients.
|
|
Academic Article
|
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists.
|
|
Academic Article
|
The nonthiazolidinedione tyrosine-based peroxisome proliferator-activated receptor gamma ligand GW7845 induces apoptosis and limits migration and invasion of rat and human glioma cells.
|
|
Academic Article
|
Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide.
|
|
Academic Article
|
The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.
|
|
Academic Article
|
PPARgamma as a therapeutic target in central nervous system diseases.
|
|
Academic Article
|
Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
|
|
Academic Article
|
Reduction of amyloid angiopathy and Abeta plaque burden after enriched housing in TgCRND8 mice: involvement of multiple pathways.
|
|
Academic Article
|
Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
|
|
Academic Article
|
Inflammatory processes in Alzheimer's disease.
|
|
Academic Article
|
Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model.
|
|
Academic Article
|
Switching on the lights for gene therapy.
|
|
Academic Article
|
PPARs in the brain.
|
|
Academic Article
|
The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications.
|
|
Academic Article
|
Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism.
|
|
Academic Article
|
Loss of gamma-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis.
|
|
Academic Article
|
NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits.
|
|
Academic Article
|
Neuroglia in neurodegeneration.
|
|
Academic Article
|
Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease.
|
|
Academic Article
|
Neuroinflammatory processes in Alzheimer's disease.
|
|
Academic Article
|
Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion.
|
|
Academic Article
|
Restraint stress increases neuroinflammation independently of amyloid ? levels in amyloid precursor protein/PS1 transgenic mice.
|
|
Academic Article
|
Microglial activation in a neuroinflammational animal model of schizophrenia--a pilot study.
|
|
Academic Article
|
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers.
|
|
Academic Article
|
Nitration of tyrosine 10 critically enhances amyloid ? aggregation and plaque formation.
|
|
Academic Article
|
Opposing roles for CXCR3 signaling in central nervous system versus ocular inflammation mediated by the astrocyte-targeted production of IL-12.
|
|
Academic Article
|
TLR2 is a primary receptor for Alzheimer's amyloid ? peptide to trigger neuroinflammatory activation.
|
|
Academic Article
|
Nitric oxide decreases the enzymatic activity of insulin degrading enzyme in APP/PS1 mice.
|
|
Academic Article
|
Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice.
|
|
Academic Article
|
Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment.
|
|
Academic Article
|
Norepinephrine increases I kappa B alpha expression in astrocytes.
|
|
Academic Article
|
Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma.
|
|
Academic Article
|
Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
|
|
Academic Article
|
Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells.
|
|
Academic Article
|
Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors.
|
|
Academic Article
|
PPAR?/RXRa-induced and CD36-mediated microglial amyloid-? phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.
|
|
Academic Article
|
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice.
|
|
Academic Article
|
The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study.
|
|
Academic Article
|
Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression.
|
|
Academic Article
|
Noradrenaline induces expression of peroxisome proliferator activated receptor gamma (PPARgamma) in murine primary astrocytes and neurons.
|
|
Academic Article
|
Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase.
|
|
Academic Article
|
Interleukin-1 beta and lipopolysaccharide decrease soluble guanylyl cyclase in brain cells: NO-independent destabilization of protein and NO-dependent decrease of mRNA.
|
|
Academic Article
|
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.
|
|
Academic Article
|
Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
|
|
Academic Article
|
Systemic inflammation induces apoptosis with variable vulnerability of different brain regions.
|
|
Academic Article
|
Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients.
|
|
Academic Article
|
Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice.
|
|
Academic Article
|
Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.
|
|
Academic Article
|
Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice.
|
|
Academic Article
|
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
|
|
Academic Article
|
Disease-modifying therapies in Alzheimer's disease: how far have we come?
|
|
Academic Article
|
GGA1 is expressed in the human brain and affects the generation of amyloid beta-peptide.
|
|
Academic Article
|
Imaging-guided gene therapy of experimental gliomas.
|
|
Academic Article
|
Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector.
|
|
Academic Article
|
Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders.
|
|
Academic Article
|
Cerebral haemodynamics and carbon dioxide reactivity during sepsis syndrome.
|
|
Academic Article
|
PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.
|
|
Academic Article
|
PPARs in Alzheimer's Disease.
|
|
Academic Article
|
Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors.
|
|
Academic Article
|
PPAR Gamma Activators: Off-Target Against Glioma Cell Migration and Brain Invasion.
|
|
Academic Article
|
Noradrenergic denervation facilitates the release of acetylcholine and serotonin in the hippocampus: towards a mechanism underlying upregulations described in MCI patients.
|
|
Academic Article
|
PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.
|
|
Academic Article
|
alpha-secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Abeta generation.
|
|
Academic Article
|
Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia.
|
|
Academic Article
|
Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.
|
|
Academic Article
|
Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.
|
|
Academic Article
|
Distinct modulation of microglial amyloid ? phagocytosis and migration by neuropeptides (i).
|
|
Academic Article
|
Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice.
|
|
Academic Article
|
Neuroinflammatory and behavioural changes in the Atp7B mutant mouse model of Wilson's disease.
|
|
Academic Article
|
Extracellular phosphorylation of the amyloid ?-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease.
|
|
Academic Article
|
Critical role of astroglial apolipoprotein E and liver X receptor-a expression for microglial A? phagocytosis.
|
|
Academic Article
|
Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease.
|
|
Academic Article
|
Glial cells in (patho)physiology.
|
|
Academic Article
|
Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease.
|
|
Academic Article
|
Impact and Therapeutic Potential of PPARs in Alzheimer's Disease.
|
|
Academic Article
|
A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis.
|
|
Academic Article
|
Long-term neuromuscular sequelae of critical illness.
|
|
Academic Article
|
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.
|
|
Academic Article
|
Mrp14 deficiency ameliorates amyloid ? burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing.
|
|
Academic Article
|
Clinical symptoms and risk factors in cerebral microangiopathy patients.
|
|
Academic Article
|
CNS-targeted production of IL-17A induces glial activation, microvascular pathology and enhances the neuroinflammatory response to systemic endotoxemia.
|
|
Academic Article
|
Studying M1 and M2 states in adult microglia.
|
|
Concept
|
Cytokines
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Insulin
|
|
Concept
|
Age Factors
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Precision Medicine
|
|
Concept
|
Caregivers
|
|
Concept
|
Central Nervous System Diseases
|
|
Concept
|
Microvessels
|
|
Concept
|
Ki-67 Antigen
|
|
Concept
|
MPTP Poisoning
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Extracellular Space
|
|
Concept
|
Amyloid beta-Protein Precursor
|
|
Concept
|
Interferon-beta
|
|
Concept
|
Synaptosomes
|
|
Concept
|
Biflavonoids
|
|
Concept
|
Survival Rate
|
|
Concept
|
Imaging, Three-Dimensional
|
|
Concept
|
Blood-Brain Barrier
|
|
Concept
|
NF-kappa B
|
|
Concept
|
Caspase 1
|
|
Concept
|
Vesicular Acetylcholine Transport Proteins
|
|
Concept
|
Myelin Sheath
|
|
Concept
|
Eosinophil-Derived Neurotoxin
|
|
Concept
|
Interferon-gamma
|
|
Concept
|
ADAM Proteins
|
|
Concept
|
Adrenergic beta-Agonists
|
|
Concept
|
Cell Lineage
|
|
Concept
|
Prostaglandin D2
|
|
Concept
|
Animals, Newborn
|
|
Concept
|
Cyclin-Dependent Kinase 5
|
|
Concept
|
Cerebellum
|
|
Concept
|
Mitochondria
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Dideoxynucleosides
|
|
Concept
|
Meliaceae
|
|
Concept
|
Incidence
|
|
Concept
|
Brain Diseases
|
|
Concept
|
Frontal Lobe
|
|
Concept
|
Excitatory Postsynaptic Potentials
|
|
Concept
|
HeLa Cells
|
|
Concept
|
Embryo, Mammalian
|
|
Concept
|
Doxorubicin
|
|
Concept
|
Alum Compounds
|
|
Concept
|
Cell Division
|
|
Concept
|
Neurofilament Proteins
|
|
Concept
|
Presynaptic Terminals
|
|
Concept
|
Carbon Dioxide
|
|
Concept
|
Age of Onset
|
|
Concept
|
ADP-Ribosylation Factors
|
|
Concept
|
Actins
|
|
Concept
|
Lanosterol
|
|
Concept
|
Phospholipase D
|
|
Concept
|
Gene Expression
|
|
Concept
|
COS Cells
|
|
Concept
|
Receptors, Endothelin
|
|
Concept
|
RNA Interference
|
|
Concept
|
Air Pollutants
|
|
Concept
|
Cholinesterase Inhibitors
|
|
Concept
|
Insulysin
|
|
Concept
|
Isoproterenol
|
|
Concept
|
Body Weight
|
|
Concept
|
Disease Progression
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Calgranulin A
|
|
Concept
|
Radiopharmaceuticals
|
|
Concept
|
Cadherins
|
|
Concept
|
Ceramides
|
|
Concept
|
Amyotrophic Lateral Sclerosis
|
|
Concept
|
Information Storage and Retrieval
|
|
Concept
|
Axons
|
|
Concept
|
Cell Adhesion Molecules
|
|
Concept
|
Chemokine CCL17
|
|
Concept
|
HSP70 Heat-Shock Proteins
|
|
Concept
|
Cell Adhesion
|
|
Concept
|
Neurites
|
|
Concept
|
Golgi Apparatus
|
|
Concept
|
DNA Fragmentation
|
|
Concept
|
Serotonin
|
|
Concept
|
Tretinoin
|
|
Concept
|
Cricetinae
|
|
Concept
|
Administration, Oral
|
|
Concept
|
Critical Illness
|
|
Concept
|
Multiple Sclerosis, Relapsing-Remitting
|
|
Concept
|
Lysosomes
|
|
Concept
|
Dentate Gyrus
|
|
Concept
|
Body Fluids
|
|
Concept
|
Jurkat Cells
|
|
Concept
|
Brain Ischemia
|
|
Concept
|
Open Reading Frames
|
|
Concept
|
Glial Fibrillary Acidic Protein
|
|
Concept
|
Herpesvirus 1, Human
|
|
Concept
|
Interleukin-23
|
|
Concept
|
Carrier Proteins
|
|
Concept
|
Myeloid Differentiation Factor 88
|
|
Concept
|
Encephalomyelitis, Autoimmune, Experimental
|
|
Concept
|
Chronic Disease
|
|
Concept
|
Adrenergic beta-Antagonists
|
|
Concept
|
Carbon Radioisotopes
|
|
Concept
|
Synaptic Transmission
|
|
Concept
|
Protein Biosynthesis
|
|
Concept
|
Intensive Care Units
|
|
Concept
|
Parietal Lobe
|
|
Concept
|
Quercetin
|
|
Concept
|
Ectodysplasins
|
|
Concept
|
Cohort Studies
|
|
Concept
|
DNA, Mitochondrial
|
|
Concept
|
Dopamine beta-Hydroxylase
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Cell Respiration
|
|
Concept
|
Stroke
|
|
Concept
|
Electromyography
|
|
Concept
|
Acute Disease
|
|
Concept
|
Cyclic AMP-Dependent Protein Kinases
|
|
Concept
|
CHO Cells
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Exosomes
|
|
Concept
|
Salmonella
|
|
Concept
|
Cerebellar Ataxia
|
|
Concept
|
Tumor Stem Cell Assay
|
|
Concept
|
Diabetes Mellitus
|
|
Concept
|
Cricetulus
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Frontotemporal Dementia
|
|
Concept
|
CA3 Region, Hippocampal
|
|
Concept
|
Protein Interaction Domains and Motifs
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Concept
|
Microdissection
|
|
Concept
|
Matrix Metalloproteinases, Membrane-Associated
|
|
Concept
|
Ketoglutaric Acids
|
|
Concept
|
Caspase 3
|
|
Concept
|
Leukocyte Count
|
|
Concept
|
Enzyme Induction
|
|
Concept
|
Language
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Functional Laterality
|
|
Concept
|
Nitroprusside
|
|
Concept
|
DNA Primers
|
|
Concept
|
Vinculin
|
|
Concept
|
tau Proteins
|
|
Concept
|
Endopeptidases
|
|
Concept
|
Dizziness
|
|
Concept
|
Neprilysin
|
|
Concept
|
Epilepsy
|
|
Concept
|
Drug Evaluation, Preclinical
|
|
Concept
|
Milk
|
|
Concept
|
Orphan Nuclear Receptors
|
|
Concept
|
Encephalitis
|
|
Concept
|
Transcription, Genetic
|
|
Concept
|
Leukocytes
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Acetylcholinesterase
|
|
Concept
|
Electroencephalography
|
|
Concept
|
Dinoprostone
|
|
Concept
|
Receptors, Bradykinin
|
|
Concept
|
Matrix Metalloproteinase 9
|
|
Concept
|
Patch-Clamp Techniques
|
|
Concept
|
Estrogens
|
|
Concept
|
Cerebral Cortex
|
|
Concept
|
Acetamides
|
|
Concept
|
Diabetes Mellitus, Type 2
|
|
Concept
|
Vital Capacity
|
|
Concept
|
Complement System Proteins
|
|
Concept
|
Chromosomes, Human, Pair 9
|
|
Concept
|
Cyclic GMP
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Toll-Like Receptor 2
|
|
Concept
|
Phospholipase C gamma
|
|
Concept
|
DNA Repeat Expansion
|
|
Concept
|
Computational Biology
|
|
Concept
|
Cells, Cultured
|
|
Concept
|
Chromogranin A
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Huntington Disease
|
|
Concept
|
Oxygen
|
|
Concept
|
Receptors, Formyl Peptide
|
|
Concept
|
Cytoplasm
|
|
Concept
|
Calgranulin B
|
|
Concept
|
Phosphopyruvate Hydratase
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Microtubule-Associated Proteins
|
|
Concept
|
Monocytes
|
|
Concept
|
Drosophila
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Frontotemporal Lobar Degeneration
|
|
Concept
|
Granulocytes
|
|
Concept
|
Peroxisome Proliferator-Activated Receptors
|
|
Concept
|
Antipsychotic Agents
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Blood Gas Analysis
|
|
Concept
|
Endophthalmitis
|
|
Concept
|
Interleukin-1
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Tumor Necrosis Factors
|
|
Concept
|
Genes, Reporter
|
|
Concept
|
Cerebral Amyloid Angiopathy
|
|
Concept
|
STAT4 Transcription Factor
|
|
Concept
|
Communicable Disease Control
|
|
Concept
|
CD11b Antigen
|
|
Concept
|
Synapses
|
|
Concept
|
Dendritic Spines
|
|
Concept
|
Brain Injuries
|
|
Concept
|
Plant Extracts
|
|
Concept
|
Acetylcholine
|
|
Concept
|
Endotoxemia
|
|
Concept
|
Interleukin-17
|
|
Concept
|
Cerebrospinal Fluid
|
|
Concept
|
Hepatolenticular Degeneration
|
|
Concept
|
Cell Membrane
|
|
Concept
|
Cell Membrane Structures
|
|
Concept
|
Language Tests
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
Norepinephrine
|
|
Concept
|
Outpatient Clinics, Hospital
|
|
Concept
|
Neurofibrillary Tangles
|
|
Concept
|
Green Fluorescent Proteins
|
|
Concept
|
Interleukin-1beta
|
|
Concept
|
Lymphocyte Activation
|
|
Concept
|
Temporal Lobe
|
|
Concept
|
Nerve Growth Factors
|
|
Concept
|
Calcium-Binding Proteins
|
|
Concept
|
Proto-Oncogene Proteins pp60(c-src)
|
|
Concept
|
Antioxidants
|
|
Concept
|
Ephrin-B2
|
|
Concept
|
Cytoskeleton
|
|
Concept
|
Alzheimer Disease
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Entorhinal Cortex
|
|
Concept
|
Amyloid Precursor Protein Secretases
|
|
Concept
|
Isoaspartic Acid
|
|
Concept
|
Cycloheximide
|
|
Concept
|
Dementia
|
|
Concept
|
Bromodeoxyuridine
|
|
Concept
|
Prevalence
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Lewy Body Disease
|
|
Concept
|
Calcium Signaling
|
|
Concept
|
Microfilament Proteins
|
|
Concept
|
Nitrites
|
|
Concept
|
Fluorodeoxyglucose F18
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Housing, Animal
|
|
Concept
|
PPAR gamma
|
|
Concept
|
I-kappa B Proteins
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Image Processing, Computer-Assisted
|
|
Concept
|
Ferritins
|
|
Concept
|
Interleukin-18
|
|
Concept
|
Neural Conduction
|
|
Concept
|
Evidence-Based Medicine
|
|
Concept
|
Receptors, N-Methyl-D-Aspartate
|
|
Concept
|
Epilepsy, Temporal Lobe
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
Immunization
|
|
Concept
|
Forced Expiratory Volume
|
|
Concept
|
Interleukin-12
|
|
Concept
|
Herpesvirus 7, Human
|
|
Concept
|
Multiple Sclerosis
|
|
Concept
|
Proteomics
|
|
Concept
|
Supranuclear Palsy, Progressive
|
|
Concept
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2
|
|
Concept
|
Bacterial Infections
|
|
Concept
|
Cell Line
|
|
Concept
|
Locus Coeruleus
|
|
Concept
|
Adenosine Triphosphatases
|
|
Concept
|
Cerebellar Nuclei
|
|
Concept
|
Aspartic Acid Endopeptidases
|
|
Concept
|
Mediator Complex Subunit 1
|
|
Concept
|
Raclopride
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Rifabutin
|
|
Concept
|
Coronavirus Infections
|
|
Concept
|
Limbic System
|
|
Concept
|
Hippocampus
|
|
Concept
|
Chlamydophila pneumoniae
|
|
Concept
|
Bayes Theorem
|
|
Concept
|
Cytochromes c
|
|
Concept
|
Culture Media, Conditioned
|
|
Concept
|
Vaccination
|
|
Concept
|
Parkinson Disease
|
|
Concept
|
Cholesterol
|
|
Concept
|
Herpesvirus 6, Human
|
|
Concept
|
Cerebrum
|
|
Concept
|
Piracetam
|
|
Concept
|
Somatosensory Cortex
|
|
Concept
|
Ibuprofen
|
|
Concept
|
Chemokine CXCL10
|
|
Concept
|
Gangliosides
|
|
Concept
|
Risk Factors
|
|
Concept
|
Chemokines
|
|
Concept
|
Visual Cortex
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Copper
|
|
Concept
|
Receptors, CCR2
|
|
Concept
|
Benzylamines
|
|
Concept
|
Cation Transport Proteins
|
|
Concept
|
Metalloendopeptidases
|
|
Concept
|
Arginase
|
|
Concept
|
Dementia, Vascular
|
|
Concept
|
Chemokine CXCL9
|
|
Concept
|
Base Sequence
|
|
Concept
|
Alleles
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Interferon Type I
|
|
Concept
|
Amyloid beta-Peptides
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Luminescence
|
|
Concept
|
Comorbidity
|
|
Concept
|
3',5'-Cyclic-GMP Phosphodiesterases
|
|
Concept
|
CD36 Antigens
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Brain-Derived Neurotrophic Factor
|
|
Concept
|
Molecular Sequence Data
|
|
Concept
|
Antibiotics, Antineoplastic
|
|
Concept
|
Lymphocyte Subsets
|
|
Concept
|
Neuroimmunomodulation
|
|
Concept
|
Cell Count
|
|
Concept
|
CARD Signaling Adaptor Proteins
|
|
Concept
|
Critical Care
|
|
Concept
|
Matrix Metalloproteinases
|
|
Academic Article
|
ADO: a disease ontology representing the domain knowledge specific to Alzheimer's disease.
|
|
Academic Article
|
Gray matter atrophy pattern in elderly with subjective memory impairment.
|
|
Academic Article
|
Long-term cerebral consequences of sepsis.
|
|
Academic Article
|
Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease.
|
|
Academic Article
|
Innate immune activation in neurodegenerative disease.
|
|
Academic Article
|
Ear2 deletion causes early memory and learning deficits in APP/PS1 mice.
|
|
Academic Article
|
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
|
|
Academic Article
|
CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system.
|
|
Academic Article
|
Truncated and modified amyloid-beta species.
|
|
Academic Article
|
Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia.
|
|
Academic Article
|
Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction.
|
|
Academic Article
|
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration.
|
|
Academic Article
|
Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.
|
|
Academic Article
|
SUCLG2 identified as both a determinator of CSF A?1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.
|
|
Academic Article
|
Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.
|
|
Academic Article
|
Sepsis-associated encephalopathy versus sepsis-induced encephalopathy--authors' reply.
|
|
Academic Article
|
CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.
|
|
Academic Article
|
Cortical thinning in individuals with subjective memory impairment.
|
|
Academic Article
|
Pan-PPAR modulation effectively protects APP/PS1 mice from amyloid deposition and cognitive deficits.
|
|
Academic Article
|
PLD3 in non-familial Alzheimer's disease.
|
|
Academic Article
|
Innate immunity in Alzheimer's disease.
|
|
Academic Article
|
Neuroinflammation in Alzheimer's disease.
|
|
Academic Article
|
Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
|
|
Academic Article
|
Effect of pioglitazone medication on the incidence of dementia.
|
|
Academic Article
|
A distinct clinical phenotype in a German kindred with motor neuron disease carrying a CHCHD10 mutation.
|
|
Academic Article
|
?-Secretase processing of APP inhibits neuronal activity in the hippocampus.
|
|
Academic Article
|
Reduction of microbleeds by immunosuppression in a patient with A?-related vascular inflammation.
|
|
Academic Article
|
Microglia in Alzheimer's disease: the good, the bad and the ugly.
|
|
Academic Article
|
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.
|
|
Academic Article
|
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers.
|
|
Academic Article
|
Thoughts on Obesity and Brain Glucose.
|
|
Academic Article
|
Early Changes in Hippocampal Neurogenesis in Transgenic Mouse Models for Alzheimer's Disease.
|
|
Academic Article
|
Effect of pioglitazone treatment in a patient with secondary multiple sclerosis.
|
|
Academic Article
|
Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised.
|
|
Academic Article
|
TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
|
|
Academic Article
|
Inflammasome activation and innate immunity in Alzheimer's disease.
|
|
Academic Article
|
Danger-associated molecular patterns in Alzheimer's disease.
|
|
Academic Article
|
IL-17A Promotes Granulocyte Infiltration, Myelin Loss, Microglia Activation, and Behavioral Deficits During Cuprizone-Induced Demyelination.
|
|
Academic Article
|
Role of neuroinflammation in neurodegeneration: new insights.
|
|
Academic Article
|
Personalized genetics of the cholinergic blockade of neuroinflammation.
|
|
Academic Article
|
Intramembranous processing by ?-secretase regulates reverse signaling of ephrin-B2 in migration of microglia.
|
|
Academic Article
|
Inflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer-prone mice.
|
|
Academic Article
|
Activation of the NLRP3 inflammasome in microglia: the role of ceramide.
|
|
Academic Article
|
United Again: STING and the Police.
|
|
Academic Article
|
Microglia-derived ASC specks cross-seed amyloid-? in Alzheimer's disease.
|
|
Academic Article
|
Multicenter Resting State Functional Connectivity in Prodromal and Dementia Stages of Alzheimer's Disease.
|
|
Academic Article
|
Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
|
|
Academic Article
|
Screening for Niemann-Pick Type C Disease in a Memory Clinic Cohort.
|
|
Academic Article
|
A guiding map for inflammation.
|
|
Academic Article
|
Inflammasome signalling in brain function and neurodegenerative disease.
|
|
Academic Article
|
Cannabinoid 1 Receptor Signaling on Hippocampal GABAergic Neurons Influences Microglial Activity.
|
|
Academic Article
|
Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.
|
|
Academic Article
|
Microglia: You'll Never Walk Alone!
|
|
Academic Article
|
Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease.
|
|
Academic Article
|
The ERICA Score: An MR Imaging-based Visual Scoring System for the Assessment of Entorhinal Cortex Atrophy in Alzheimer Disease.
|
|
Academic Article
|
Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis.
|
|
Academic Article
|
Proteome profiling of s-nitrosylated synaptosomal proteins by isobaric mass tags.
|
|
Academic Article
|
Innate Immunity and Neurodegeneration.
|
|
Academic Article
|
Targeting Neuroinflammation to Treat Alzheimer's Disease.
|
|
Academic Article
|
Microglia modulation through external vagus nerve stimulation in a murine model of Alzheimer's disease.
|
|
Academic Article
|
Neuroinflammatory responses in Alzheimer's disease.
|
|
Academic Article
|
Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
|
|
Academic Article
|
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
|
|
Academic Article
|
Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration.
|
|
Academic Article
|
Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-? plaques: A potential role in shaping plaque pathology?
|
|
Academic Article
|
A novel CHCHD10 mutation implicates a Mia40-dependent mitochondrial import deficit in ALS.
|
|
Academic Article
|
Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease-Data from three memory clinic studies.
|
|
Academic Article
|
Tau plasma levels in subjective cognitive decline: Results from the DELCODE study.
|
|
Academic Article
|
Variability and temporal dynamics of novel object recognition in aging male C57BL/6 mice.
|
|
Academic Article
|
The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (A?) species on long-term potentiation (LTP).
|
|
Academic Article
|
Microglia in Alzheimer's disease.
|
|
Academic Article
|
CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume.
|
|
Academic Article
|
Microglia take centre stage in neurodegenerative disease.
|
|
Academic Article
|
Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples.
|
|
Academic Article
|
Author Correction: Inflammasome signalling in brain function and neurodegenerative disease.
|
|
Academic Article
|
Dysregulation of TLR5 and TAM Ligands in the Alzheimer's Brain as Contributors to Disease Progression.
|
|
Academic Article
|
The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease.
|
|
Academic Article
|
CNS-Specific Synthesis of Interleukin 23 Induces a Progressive Cerebellar Ataxia and the Accumulation of Both T and B Cells in the Brain: Characterization of a Novel Transgenic Mouse Model.
|
|
Academic Article
|
Elevated levels of Secreted-Frizzled-Related-Protein 1 contribute to Alzheimer's disease pathogenesis.
|
|
Academic Article
|
Systemic inflammation impairs microglial A? clearance through NLRP3 inflammasome.
|
|
Academic Article
|
Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.
|
|
Academic Article
|
Microglia in Neurodegenerative Disorders.
|
|
Academic Article
|
In Vivo Phagocytosis Analysis of Amyloid Beta.
|
|
Academic Article
|
[Neuroinflammation as motor of Alzheimer's disease].
|
|
Academic Article
|
Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey.
|
|
Academic Article
|
A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2.
|
|
Academic Article
|
Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment.
|
|
Academic Article
|
Quantitative proteomics of synaptosome S-nitrosylation in Alzheimer's disease.
|
|
Academic Article
|
Higher CSF Tau Levels Are Related to Hippocampal Hyperactivity and Object Mnemonic Discrimination in Older Adults.
|
|
Academic Article
|
Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer's Disease Spectrum: Association with Amyloid Pathology and Diagnostic Usefulness.
|
|
Academic Article
|
The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.
|
|
Academic Article
|
Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study.
|
|
Academic Article
|
Norepinephrine as a modulator of microglial dynamics.
|
|
Academic Article
|
Inflammasome-mediated innate immunity in Alzheimer's disease.
|
|
Academic Article
|
NLRP3 inflammasome activation drives tau pathology.
|
|
Academic Article
|
Vaccination with (1-11)E2 in alum efficiently induces an antibody response to ?-amyloid without affecting brain ?-amyloid load and microglia activation in 3xTg mice.
|
|
Academic Article
|
In vivo characterization of functional states of cortical microglia during peripheral inflammation.
|
|
Academic Article
|
Soluble A? oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.
|
|
Academic Article
|
An immune-cell signature marks the brain in Alzheimer's disease.
|
|
Academic Article
|
Microglia in Alzheimer's disease: Local heroes!
|
|
Academic Article
|
Do infections have a role in the pathogenesis of Alzheimer disease?
|
|
Academic Article
|
Neuroimmune Connections in Aging and Neurodegenerative Diseases.
|
|
Academic Article
|
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment.
|
|
Academic Article
|
?-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia.
|
|
Academic Article
|
T cells in Alzheimer's disease: space invaders.
|
|
Academic Article
|
The Entorhinal Cortex Atrophy Score Is Diagnostic and Prognostic in Mild Cognitive Impairment.
|
|
Academic Article
|
Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease.
|
|
Academic Article
|
Enduring Changes in Neuronal Function upon Systemic Inflammation Are NLRP3 Inflammasome Dependent.
|
|
Academic Article
|
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease.
|
|
Academic Article
|
Minor neuropsychological deficits in patients with subjective cognitive decline.
|
|
Academic Article
|
Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients.
|
|
Academic Article
|
Interrelations of Alzheimer?s disease candidate biomarkers neurogranin, fatty acid-binding protein 3 and ferritin to neurodegeneration and neuroinflammation.
|
|
Academic Article
|
Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study.
|
|
Academic Article
|
mTOR-dependent translation amplifies microglia priming in aging mice.
|
|
Academic Article
|
Author Correction: A guiding map for inflammation.
|
|
Academic Article
|
Time course of dementia following sepsis in German health claims data.
|
|
Academic Article
|
Major Surgery Affects Memory in Individuals with Cerebral Amyloid-? Pathology.
|
|
Academic Article
|
Multimodal MRI analysis of basal forebrain structure and function across the Alzheimer's disease spectrum.
|
|
Academic Article
|
Novel Phosphorylation-State Specific Antibodies Reveal Differential Deposition of Ser26 Phosphorylated A? Species in a Mouse Model of Alzheimer's Disease.
|
|
Academic Article
|
Deletion of the inflammatory S100-A9/MRP14 protein does not influence survival in hSOD1G93A ALS mice.
|
|
Academic Article
|
Astrocyte-specific expression of interleukin 23 leads to an aggravated phenotype and enhanced inflammatory response with B cell accumulation in the EAE model.
|
|
Academic Article
|
Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age.
|
|
Academic Article
|
Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive Decline.
|
|
Academic Article
|
In vivo mechanisms of cortical network dysfunction induced by systemic inflammation.
|
|
Academic Article
|
Resting-State Network Alterations Differ between Alzheimer's Disease Atrophy Subtypes.
|
|
Academic Article
|
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
|
|
Academic Article
|
Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in Alzheimer's disease.
|
|
Academic Article
|
Long-term exposure to fine particulate matter, lung function and cognitive performance: A prospective Dutch cohort study on the underlying routes.
|
|
Academic Article
|
Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing.
|
|
Academic Article
|
Differential interaction with TREM2 modulates microglial uptake of modified A? species.
|
|
Academic Article
|
Microglial NLRP3 Inflammasome Activation upon TLR2 and TLR5 Ligation by Distinct a-Synuclein Assemblies.
|
|
Academic Article
|
Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus.
|
|
Academic Article
|
Proteopathic tau primes and activates interleukin-1? via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway.
|
|
Academic Article
|
Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes.
|
|
Academic Article
|
Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin Study.
|
|
Academic Article
|
Publisher Correction: Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus.
|
|
Academic Article
|
SFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation.
|
|
Academic Article
|
mTOR-dependent translation amplifies microglia priming in aging mice.
|
|
Academic Article
|
A microRNA signature that correlates with cognition and is a target against cognitive decline.
|
|
Academic Article
|
TREM2 modulates differential deposition of modified and non-modified A? species in extracellular plaques and intraneuronal deposits.
|
|
Academic Article
|
Microglial PD-1 stimulation by astrocytic PD-L1 suppresses neuroinflammation and Alzheimer's disease pathology.
|
|
Academic Article
|
Cerebral dysfunctions caused by sepsis during ageing.
|
|
Academic Article
|
Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer's disease.
|
|
Academic Article
|
Inflammasome activation in neurodegenerative diseases.
|
|
Academic Article
|
Characteristics of subjective cognitive decline associated with amyloid positivity.
|
|
Academic Article
|
Impact of COVID-19 on the Onset and Progression of Alzheimer's Disease and Related Dementias: A Roadmap for Future Research.
|
|
Academic Article
|
Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.
|
|
Academic Article
|
Teaching an old dog new tricks: serum troponin T as a biomarker in amyotrophic lateral sclerosis.
|
|
Academic Article
|
Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer's disease.
|
|
Academic Article
|
p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function.
|
|
Concept
|
Extracellular Vesicles
|
|
Concept
|
Infectious Encephalitis
|
|
Concept
|
Machine Learning
|
|
Concept
|
Interferon beta-1a
|
|
Concept
|
NLR Family, Pyrin Domain-Containing 3 Protein
|
|
Concept
|
Chitinase-3-Like Protein 1
|
|
Concept
|
Sequestosome-1 Protein
|
|
Concept
|
Liver X Receptors
|
|
Concept
|
NF-KappaB Inhibitor alpha
|
|
Concept
|
ADAM10 Protein
|
|
Concept
|
Protein Domains
|
|
Concept
|
Healthy Aging
|
|
Concept
|
2-Hydroxypropyl-beta-cyclodextrin
|
|
Concept
|
Copper-transporting ATPases
|
|
Concept
|
THP-1 Cells
|
|
Concept
|
HEK293 Cells
|
|
Concept
|
Single-Cell Analysis
|
|
Concept
|
Diagnostic Self Evaluation
|
|
Concept
|
Diet, High-Fat
|
|
Concept
|
Cerebral Small Vessel Diseases
|
|
Concept
|
Transcriptome
|
|
Concept
|
Brain Waves
|
|
Concept
|
Pandemics
|
|
Concept
|
Cognitive Dysfunction
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
Programmed Cell Death 1 Receptor
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Memory, Episodic
|
|
Concept
|
Sepsis-Associated Encephalopathy
|
|
Concept
|
Benign Paroxysmal Positional Vertigo
|
|
Concept
|
Support Vector Machine
|
|
Concept
|
Clustered Regularly Interspaced Short Palindromic Repeats
|
|
Concept
|
Datasets as Topic
|
|
Concept
|
Protective Factors
|
|
Concept
|
White Matter
|
|
Concept
|
Gray Matter
|
|
Concept
|
Basal Forebrain
|
|
Academic Article
|
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
|
|
Academic Article
|
Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's Disease.
|
|
Academic Article
|
Amyloid pathology but not APOE e4 status is permissive for tau-related hippocampal dysfunction.
|
|
Academic Article
|
New insights into the genetic etiology of Alzheimer's disease and related dementias.
|
|
Academic Article
|
Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers.
|
|
Academic Article
|
Falls at advanced age - The importance to search for benign paroxysmal positional vertigo (BPPV).
|
|
Academic Article
|
Feasibility of Digital Memory Assessments in an Unsupervised and Remote Study Setting.
|
|
Academic Article
|
Reactive microglia are the major source of tumor necrosis factor alpha and contribute to astrocyte dysfunction and acute seizures in experimental temporal lobe epilepsy.
|
|
Academic Article
|
Lifelong experiences as a proxy of cognitive reserve moderate the association between connectivity and cognition in Alzheimer's disease.
|
|
Academic Article
|
Novelty-Related fMRI Responses of Precuneus and Medial Temporal Regions in Individuals at Risk for Alzheimer Disease.
|
|
Academic Article
|
ApoE4 makes microglia trem2bling.
|
|
Academic Article
|
Cholinergic white matter pathways along the Alzheimer's disease continuum.
|
|
Academic Article
|
Microglia states and nomenclature: A field at its crossroads.
|
|
Academic Article
|
The Contribution of the Locus Coeruleus-Noradrenaline System Degeneration during the Progression of Alzheimer's Disease.
|
|
Academic Article
|
CNS Superficial Siderosis Mimicking a Motor Neuron Disease.
|
|
Academic Article
|
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.
|
|
Academic Article
|
Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve.
|
|
Academic Article
|
Infection and inflammation: New perspectives on Alzheimer's disease.
|
|
Academic Article
|
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.
|
|
Academic Article
|
Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
|
|
Academic Article
|
NLRP3-directed antisense oligonucleotides reduce microglial immunoactivities in vitro.
|
|
Academic Article
|
A Residual Marker of Cognitive Reserve Is Associated with Resting-State Intrinsic Functional Connectivity Along the Alzheimer's Disease Continuum.
|
|
Academic Article
|
Brain reserve contributes to distinguishing preclinical Alzheimer's stages 1 and 2.
|
|
Academic Article
|
Exploring the ATN classification system using brain morphology.
|
|
Academic Article
|
APOE and immunity: Research highlights.
|
|
Academic Article
|
Chronic inflammation: a potential target in tauopathies.
|
|
Academic Article
|
ARG1-expressing microglia show a distinct molecular signature and modulate postnatal development and function of the mouse brain.
|
|
Academic Article
|
Sporadic Use of Antibiotics in Older Adults and the Risk of Dementia: A Nested Case-Control Study Based on German Health Claims Data.
|
|
Academic Article
|
Brain Volume Changes after COVID-19 Compared to Healthy Controls by Artificial Intelligence-Based MRI Volumetry.
|
|
Academic Article
|
The role of peripheral inflammatory insults in Alzheimer's disease: a review and research roadmap.
|
|
Academic Article
|
Characterizing microglial senescence: Tau as a key player.
|
|
Academic Article
|
Phosphorylation-state dependent intraneuronal sorting of A? differentially impairs autophagy and the endo-lysosomal system.
|
|
Academic Article
|
[Parkinson's and Alzheimer's disease as system-wide neurodegenerative disorders].
|
|
Academic Article
|
Machine learning-based classification of Alzheimer's disease and its at-risk states using personality traits, anxiety, and depression.
|
|
Academic Article
|
Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive Decline.
|
|
Academic Article
|
Cognitive Trajectories in Preclinical and Prodromal Alzheimer's Disease Related to Amyloid Status and Brain Atrophy: A Bayesian Approach.
|
|
Academic Article
|
Microglia heterogeneity in health and disease.
|
|
Academic Article
|
Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline.
|
|
Academic Article
|
Inflammasomes in neurological disorders - mechanisms and therapeutic potential.
|
|
Academic Article
|
Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition.
|
|
Academic Article
|
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis.
|
|
Academic Article
|
Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease.
|
|
Academic Article
|
Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer's Disease Patients?
|
|
Academic Article
|
Immune Activation in Alzheimer Disease.
|
|
Academic Article
|
The endotoxin hypothesis of Alzheimer's disease.
|
|
Academic Article
|
Innate immune activation in neurodegenerative diseases.
|
|
Academic Article
|
TREM1 is the new kid on the block for the aging-associated innate immune response and Alzheimer's disease.
|
|
Academic Article
|
Inferior Frontal Sulcal Hyperintensities on Brain MRI Are Associated with Amyloid Positivity beyond Age-Results from the Multicentre Observational DELCODE Study.
|
|
Academic Article
|
SARS-CoV-2 infection as a cause of neurodegeneration.
|
|
Academic Article
|
Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.
|
|
Academic Article
|
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS.
|
|
Academic Article
|
Machine Learning-Based Perivascular Space Volumetry in Alzheimer Disease.
|
|
Academic Article
|
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.
|
|
Academic Article
|
Plasma amyloid beta X-42/X-40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease.
|
|
Academic Article
|
A? oligomers peak in early stages of Alzheimer's disease preceding tau pathology.
|
|
Academic Article
|
Single-value brain activity scores reflect both severity and risk across the Alzheimer's continuum.
|
|
Academic Article
|
Biflavonoid Methylchamaejasmin and Khaya grandifoliola?Extract Inhibit NLRP3 Inflammasome in THP-1 Cell Model of Neuroinflammation.
|
|
Academic Article
|
Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes.
|
|
Academic Article
|
Tracking neuroinflammatory biomarkers in Alzheimer's disease: a strategy for individualized therapeutic approaches?
|
|
Academic Article
|
Fully Automated MRI-based Analysis of the Locus Coeruleus in Aging and Alzheimer's Disease Dementia using ELSI-Net.
|
|
Academic Article
|
Inflammatory aspects of Alzheimer's disease.
|
|
Academic Article
|
Association of Neurogranin and BACE1 With Clinical Cognitive Decline in Individuals With Subjective Cognitive Decline.
|
|
Academic Article
|
The putative contribution of cellular senescence to driving tauopathies.
|
|
Academic Article
|
Tunneling Nanotubes in the Brain.
|
|
Academic Article
|
The role of leukocytes in cognitive impairment due to long-term exposure to fine particulate matter: A large population-based mediation analysis.
|
|
Academic Article
|
The impact of neuroinflammation on neuronal integrity.
|
|
Academic Article
|
Perivascular space enlargement accelerates in ageing and Alzheimer's disease pathology: evidence from a three-year longitudinal multicentre study.
|
|
Academic Article
|
Cognitive reserve against Alzheimer's pathology is linked to brain activity during memory formation.
|
|
Academic Article
|
Passive anti-amyloid ? immunotherapy in Alzheimer's disease-opportunities and challenges.
|
|
Academic Article
|
Ablation of CCL17-positive hippocampal neurons induces inflammation-dependent epilepsy.
|
|
Academic Article
|
Identification of isoAsp7-A? as a major A? variant in Alzheimer's disease, dementia with Lewy bodies and vascular dementia.
|
|
Academic Article
|
Neuroinflammation in Alzheimer disease.
|
|
Academic Article
|
Blood-based quantification of A? oligomers indicates impaired clearance from brain in ApoE e4 positive subjects.
|
|
Academic Article
|
Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference.
|
|
Academic Article
|
Clinical Manifestations.
|
|
Academic Article
|
Zooming in on brain inflammation in Alzheimer's disease.
|
|
Academic Article
|
Linking higher amyloid beta 1-38 (A?(1-38)) levels to reduced Alzheimer's disease progression risk.
|
|
Academic Article
|
NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer's disease progression.
|
|
Academic Article
|
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrum.
|
|
Academic Article
|
SCD-plus features and AD biomarkers in cognitively unimpaired samples: A meta-analytic approach for nine cohort studies.
|
|
Academic Article
|
The Role of Neuroinflammation in Alzheimer's Disease: A Systematic Literature Review (P7-9.013).
|